Who Should Administer Anti-Aging Treatments
It covers the biochemistry, the evidence honestly, the regulatory status most articles skip, and how to position MIC with patients without promising something it cannot deliver
Here are two notable trials underlying these potential benefits: In a study involving 107 patients with alcohol (n = 47) or opiate (n = 60) withdrawal symptoms, DSIP was administered intravenously based on the hypothesis of its agonistic activity on opiate receptors
Response time depends on the individual, the severity of the condition, and the dosage regimen
It works by inhibiting the production of melanin, the pigment responsible for dark skin tones, effectively lightening hyperpigmentation and giving the skin a brighter, more even tone